Emtricitabine
| CAS No. | 143491-57-0 | Cat. No. | BCP02951 |
| Name | Emtricitabine | ||
| Synonyms | BW1592;BW 1592;BW-1592;Coviracil;Truvada;Atripla;Emtriva; | ||
| Formula | C8H10FN3O3S | M. Wt | 247.25 |
| Description | Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) indicated for the treatment of HIV infection in adults or combined with [tenofovir alafenamide] for the prevention of HIV-1 infection in high risk adolescents and adults. Emtricitabine is a cytidine analogue. The drug works by inhibiting HIV reverse transcriptase, preventing transcription of HIV RNA to DNA. Emtricitabine was granted FDA approval on 2 July 2003. | ||
| Pathways | Microbiology/Virology | ||
| Targets | Reverse Transcriptase HIV | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.